Cited by 114T-cell and B-cell Immunologyvaccines and immunoinformatics approachesImmunotherapy and Immune Responses

Quantitating the Magnitude of the Lymphocytic Choriomeningitis Virus-Specific CD8 T-Cell Response: It Is Even Bigger than We Thought

Open access
Masopust, David, Murali-Krishna, Kaja, Ahmed, Rafi·2007·Journal of Virology

Abstract

Measuring the magnitudes and specificities of antiviral CD8 T-cell responses is critical for understanding the dynamics and regulation of adaptive immunity. Despite many excellent studies, the accurate measurement of the total CD8 T-cell response directed against a particular infection has been hampered by an incomplete knowledge of all CD8 T-cell epitopes and also by potential contributions of bystander expansion among CD8 T cells of irrelevant specificities. Here, we use several techniques to provide a more complete accounting of the CD8 T-cell response generated upon infection of C57BL/6 mice with lymphocytic choriomeningitis virus (LCMV). Eight days following infection, we found that 85 to 95% of CD8 T cells exhibit an effector phenotype as indicated by granzyme B, 1B11, CD62L, CD11a, and CD127 expression. We demonstrate that CD8 T-cell expansion is due to cells that divide >7 times, whereas heterologous viral infections only elicited <3 divisions among bystander memory CD8 T cells. Furthermore, we found that approximately 80% of CD8 T cells in spleen were specific for ten different LCMV-derived epitopes at the peak of primary infection. These data suggest that following a single LCMV infection, effector CD8 T cells divide ≥15 times and account for at least 80%, and possibly as much as 95%, of the CD8 T-cell pool. Moreover, the response targeted a very broad array of peptide major histocompatibility complexes (MHCs), even though we examined epitopes derived from only two of the four proteins encoded by the LCMV genome and C57BL/6 mice only have two MHC class I alleles. These data illustrate the potential enormity, specificity, and breadth of CD8 T-cell responses to viral infection and demonstrate that bystander activation does not contribute to CD8 T-cell expansion.

Integrity signals

Registry

Crossref · 10.1128/jvi.01459-06

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • During an ongoing immune response, activation markers such as CD11a and CD49d can be used to directly identify Ag-experienced CD8 T cells immediately ex vivo.

    “Additionally, during an ongoing immune response, activation markers such as CD11a and CD49d [235], as well as markers of proliferation (BrdU or Ki67) (see section IV.5 Adoptive T cell transfers as a read-out for Ag-specific immune responses in mice) can be used to directly identify Ag-experienced CD8 T cells immediately ex vivo.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Masopust, D., Murali-Krishna, K., & Ahmed, R.
Affiliations
  • Emory University (US)
  • Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322
Corresponding author
Ahmed, Rafi
Venue
Journal of Virology
Published
2007-02-15
Volume
81
Issue
4
Pages
2002-2011
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2102032807
Cited by
114
References
61
Citations by year
2026: 5 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 6 · 2014: 10 · 2013: 8 · 2012: 7
FWCI
3.79
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01ai30048-10-0-1)
  • National Institute of Allergy and Infectious Diseases (P01AI044644, N01 AI030048, AI44644, AI 30048, U19AI044644)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
lymphocytic choriomeningitis virus, CD8+ T cells, antiviral T cell responses, effector T cell expansion, bystander activation, T cell epitopes, MHC class I restriction, T cell division, granzyme B, memory CD8+ T cells, viral infection
MeSH terms
Animals, Female, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Species Specificity, Spleen, CD8-Positive T-Lymphocytes, Lymphocyte Count, Epitopes, T-Lymphocyte, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review